Search

Population pharmacokinetics of daprodustat across five phase 2b/3 studies in chronic kidney disease (CKD) patients with anemia.

Therapeutic area :

Mahar K.M., Goulooze S.C., Yang S., Mesic E., Beerahee M., Post T.M.

Population pharmacokinetics of daprodustat across five phase 2b/3 studies in chronic kidney disease (CKD) patients with anemia. ACoP 2022. [Link to publication]

Our expertise

Diabetes Pain Lung Diseases Oncology Endocrinology/Sexual health General modelling Gastrointestinal Diseases Blood disorders Anesthesiology CNS Paediatrics Methods Safety pharmacology Biologicals Peripheral Nervous System Cardiovascular Anti-infectives and immunology